The COVID-19 pandemic

M Ciotti, M Ciccozzi, A Terrinoni, WC Jiang… - Critical reviews in …, 2020 - Taylor & Francis
In December 2019, an outbreak of pneumonia of unknown origin was reported in Wuhan,
Hubei Province, China. Pneumonia cases were epidemiologically linked to the Huanan …

Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis

RAT Kuswardhani, J Henrina, R Pranata… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims The ongoing COVID-19 pandemic is disproportionately affecting
patients with comorbidities. Therefore, thorough comorbidities assessment can help …

Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile

A Jara, EA Undurraga, C González… - … England Journal of …, 2021 - Mass Medical Soc
Background Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19)
are occurring in many countries; estimates of vaccine effectiveness are urgently needed to …

Socioeconomic status and well-being during COVID-19: A resource-based examination.

CR Wanberg, B Csillag, RP Douglass… - Journal of Applied …, 2020 - psycnet.apa.org
The authors assess levels and within-person changes in psychological well-being (ie,
depressive symptoms and life satisfaction) from before to during the COVID-19 pandemic for …

Review of current COVID-19 diagnostics and opportunities for further development

Y Mardian, H Kosasih, M Karyana, A Neal… - Frontiers in …, 2021 - frontiersin.org
Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …

COVID-19 and diabetes: a collision and collusion of two diseases

EL Feldman, MG Savelieff, SS Hayek, S Pennathur… - Diabetes, 2020 - Am Diabetes Assoc
The coronavirus disease 2019 (COVID-19) pandemic has infected> 22.7 million and led to
the deaths of 795,000 people worldwide. Patients with diabetes are highly susceptible to …

Risk factors and outcome of COVID-19 in patients with hematological malignancies

JL Piñana, R Martino, I García-García, R Parody… - … Hematology & Oncology, 2020 - Springer
Background Prognostic factors of poor outcome in patients with hematological malignancies
and COVID-19 are poorly defined. Patients and methods This was a Spanish transplant …

Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients

A Mendy, S Apewokin, AA Wells, AL Morrow - MedRxiv, 2020 - medrxiv.org
Background The coronavirus disease (COVID-19) first identified in Wuhan in December
2019 became a pandemic within a few months of its discovery. The impact of COVID-19 is …

Biomarkers of post-COVID depression

P Lorkiewicz, N Waszkiewicz - Journal of Clinical medicine, 2021 - mdpi.com
The COVID-19 pandemic is spreading around the world and 187 million people have
already been affected. One of its after-effects is post-COVID depression, which, according to …

Serum S100B protein as a marker of severity in Covid-19 patients

A Aceti, LM Margarucci, E Scaramucci, M Orsini… - Scientific reports, 2020 - nature.com
SARS-CoV-2 infection shows a wide-ranging clinical severity, requiring prognostic markers.
We focused on S100B, a calcium-binding protein present in biological fluids, being a …